Form 8-K SEATTLE GENETICS INC For: Oct 30

Go back to Form 8-K SEATTLE GENETICS INC For: Oct 30

Seattle Genetics (SGEN) Tops Q3 EPS by 11c

October 30, 2014 5:08 PM EDT

Seattle Genetics (NASDAQ: SGEN) reported Q3 EPS of ($0.13), $0.11 better than the analyst estimate of ($0.24). Revenue for the quarter came in at $75.8 million versus the consensus estimate of $66.9 million.

For earnings history and earnings-related data on Seattle Genetics (SGEN) click here.

... More